Editorial: Spontaneous Bacterial Peritonitis—Redrawing Empiric Therapy in the Era of Multidrug Resistance. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (4) · 533-535
DOI: 10.1111/apt.70767 ↗Kurz gefasst
Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 01.06.2026. Verfasst von Rohit Mehtani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, BLK-Max Institute of Digestive and Liver Diseases, BLK-Max Super Speciality Hospital, New Delhi, India. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, BLK-Max Institute of Digestive and Liver Diseases, BLK-Max Super Speciality Hospital, New Delhi, India.
- Department of Hepatology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
ORCID-Profile: Rohit Mehtani, Nipun Verma
Zitieren
APA
Mehtani, R., & Verma, N. (2026). Editorial: Spontaneous Bacterial Peritonitis—Redrawing Empiric Therapy in the Era of Multidrug Resistance. Authors' Reply. Alimentary Pharmacology & Therapeutics, 64(4), 533-535. https://doi.org/10.1111/apt.70767
Vancouver
Mehtani R, Verma N. Editorial: Spontaneous Bacterial Peritonitis—Redrawing Empiric Therapy in the Era of Multidrug Resistance. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;64(4):533-535. doi:10.1111/apt.70767
BibTeX
@article{Mehtani2026,
author = {Mehtani, Rohit and Verma, Nipun},
title = {Editorial: Spontaneous Bacterial Peritonitis—Redrawing Empiric Therapy in the Era of Multidrug Resistance. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {4},
pages = {533--535},
doi = {10.1111/apt.70767}
}
EUVIMED